There are now several COVID-19 vaccines that are being rolled out across the world and many more that are being developed. Tens of thousands of people participated in the clinical trials and millions of people have already been vaccinated across the globe. This means we now have good information about how effective and safe the vaccines are in the general population. However, it is also important to understand what we know about the vaccines in relation to MS.
MS Podcast – COVID Vaccination
In this podcast, Associate Professor Anneke van der Walt, a neurologist at Alfred Health in Melbourne chats with Jodi Haartsen from Multiple Sclerosis Limited about the COVID vaccines that may become available in Australia and how they might impact people living with MS.
Listen along to find out about:
- The vaccines that are likely to be available to people in Australia, and the differences between an mRNA vaccine, a viral vector vaccine and a protein-based vaccine
- How effective the vaccines are at preventing COVID-19, and more importantly, in preventing severe disease, hospitalisation and death
- How we can know that COVID-19 vaccines are safe and whether they will make the symptoms of MS worse
- Whether MS treatments will need to be changed or delayed in order to receive the vaccine
- Whether mask wearing and social distancing will be necessary once vaccines are available.
Podcast produced by Multiple Sclerosis Limited. 2021.
The information in this embedded video has been developed by the author(s) of the video. Novartis has not been involved in the creation of this content. The intent of providing this material is informational and not as advice. Any information provided by this source should be discussed with your healthcare professional and does not replace their advice.